The Review of Diabetic Studies · 2007 · 35 citations · 38 references
Life SciencesCardiologyPhysiologyCell PhysiologyCellular MetabolismMitochondrial BiologyCardiac PhysiologyCardiovascular PhysiologyMitochondrial CardiomyopathyMitochondrial DysfunctionMitochondrial PhysiologyReactive Oxygen SpeciesAngiotensin Receptor SignalingBeta-adrenergic AgentsCardiac Mitochondrial FunctionContractile Function AssessmentDiabetic CardiomyopathyMitochondrial Function In CardiomyocytesMitochondrial Reactive Oxygen Species ProductionOxidative Stress In Cardiovascular Disease
Many diabetic patients suffer from a cardiomyopathy that cannot be explained solely by poor coronary perfusion. This cardiomyopathy may be due to either organ-based damage like fibrosis, or to direct damage to cardiomyocytes. Mitochondrial-derived reactive oxygen species (ROS) have been proposed to contribute to this cardiomyopathy. To address these questions, we used the OVE26 mouse model of severe type 1 diabetes to measure contractility in isolated cardiomyocytes by edge detection and in vivo with echocardiography. We also assessed the source of ROS generation using both a general and a mitochondrial specific indicator. When contractility was assayed in freshly isolated myocytes, contraction was much stronger in control myocytes. However, contractility of normal myocytes became weaker during 24 hours of in vitro culture. In contrast, contractility of diabetic OVE26 myocytes remains stable during culture. Echocardiography revealed normal or hyperdynamic function in OVE26 hearts under basal conditions but with a sharply reduced response to isoproterenol, a beta-adrenergic agonist. For ROS generation, we found that ROS production in diabetic myocytes was elevated after exposure to either high glucose or angiotensin II (AngII). Superoxide detection with the mitochondrial sensor MitoSOX Red confirmed that mitochondria are a major source of ROS generation in diabetic myocytes. These results show that contractile deficits in OVE26 diabetic hearts are due primarily to cardiomyocyte impairment and that ROS from mitochondria are a cause of that impairment.
38
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Takeshi Nishikawa, Diane Edelstein, Xue Du et al. · Nature · 2000 · 4.3K citations
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Shirley Rubler, Joel Dlugash, Yusuf Ziya Yuceoglu et al. · The American Journal of Cardiology · 1972 · 1.9K citations
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Ulrich Hink, Huige Li, Hanke Mollnau et al. · Circulation Research · 2001 · 1.2K citations
Medicine, Biochemistry, Pharmacology +16
Evidence for Cardiomyopathy in Familial Diabetes Mellitus
Timothy J. Regan, Michael M. Lyons, S. Sultan Ahmed et al. · Journal of Clinical Investigation · 1977 · 729 citations · Full text